New diabetes tech tested in hotel study
NCT ID NCT06428591
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 35 times
Summary
This study tested a new system called Tandem Freedom in 10 adults with type 1 diabetes who already use Control-IQ technology. Participants used their usual system at home for a week, then switched to Tandem Freedom during a supervised hotel stay. The goal was to check safety by counting severe low blood sugar and diabetic ketoacidosis events, and to see how well the system kept blood sugar in a healthy range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Otago
Christchurch, 8140, New Zealand
Conditions
Explore the condition pages connected to this study.